All In MedTech

Device Trial Radar · NCT02566447

"Solana™ Trichomonas Assay Field Study"

Last checked: Nov 19, 2026Latest source record: Mar 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

750

Actual

Start

Oct 15, 2015

Primary completion

Aug 15, 2016

Study completion Aug 15, 2016

Sponsor

Lead sponsor
Quidel CorporationNot on our public-company list
Sponsor type
Industry
First posted
Oct 2, 2015

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Solana® Trichomonas Assay is an in vitro qualitative nucleic acid amplification test for the detection of Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Helicase-Dependent Amplification (HDA) technology and the Solana instrument.

Conditions

  • Trichomonas Vaginalis

Interventions

  • Solana Trichomonas Assay TestingDevice

    Specimen collection of urine and/or vaginal swabs for testing

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Trichomonas Test ResultTime frame: 2 days

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Johns Hopkins University School of Medicine

    Baltimore, Maryland

  • University of North Carolina, Div. of Infectious Diseases

    Chapel Hill, North Carolina

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.